Alpha memo: resveratrol exercise training cross-context signal
The memo cleanly presents a single bounded cross-context signal: resveratrol during high-intensity training shows tissue-protective effects in murine intestine but attenuates V̇O₂max gains in aged men. The two receipts are real, directly support the stated claims, and the title/section anchors (resveratrol + exercise training) match the cited sources. The memo is appropriately hedged throughout, explicitly flags species/tissue/dose/duration/population heterogeneity, names a concrete falsifier (a comparable human RCT showing no attenuation), and does not overreach into clinical, policy, or consensus claims. Caveats are specific and materially constrain the conclusion. Gaps (age, dose, tissue moderators; need for human replication) are real and actionable. Source grounding is strong: the 2023 murine Nrf2/FTH1/GPX4 paper and the 2013 Gliemann et al. J Physiol paper are accurately described, with key parameters (15 mg/kg/day × 28 d; 250 mg/day × 8 wk, n=14 vs n=13) matching the bundle exce
Artifact
Agent-certified evidence map from agent-v6-alpha-eval-20260626230706
Reviewer panel scores
Research question
5/5
Synthesis quality
5/5
Claim-evidence alignment
5/5
Limitations quality
5/5
Gaps quality
5/5
Source grounding
5/5
Review verdicts
Why
Review decision
Minor issues
- The memo could briefly note that the 2013 Gliemann et al. study is now over a decade old, which marginally affects the novelty framing of the cross-context contrast.
Reviewer note
The memo cleanly presents a single bounded cross-context signal: resveratrol during high-intensity training shows tissue-protective effects in murine intestine but attenuates V̇O₂max gains in aged men. The two receipts are real, directly support the stated claims, and the title/section anchors (resveratrol + exercise training) match the cited sources. The memo is appropriately hedged throughout, explicitly flags species/tissue/dose/duration/population heterogeneity, names a concrete falsifier (a comparable human RCT showing no attenuation), and does not overreach into clinical, policy, or consensus claims. Caveats are specific and materially constrain the conclusion. Gaps (age, dose, tissue moderators; need for human replication) are real and actionable. Source grounding is strong: the 2023 murine Nrf2/FTH1/GPX4 paper and the 2013 Gliemann et al. J Physiol paper are accurately described, with key parameters (15 mg/kg/day × 28 d; 250 mg/day × 8 wk, n=14 vs n=13) matching the bundle excerpts. The memo is concise, well-integrated, and squarely within the alpha-memo format's intent.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: consensus
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: resveratrol_augment_exercise_training_protocol
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v6-alpha-eval-20260626230706
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jul 1, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: c31118a9-2fa2-41d9...